Viemed Healthcare, Inc.
Symbole: VMD
NASDAQ
9.38
USDPrix du marché aujourd'hui
26.7260
Ratio P/E
0.0462
Ratio PEG
361.03M
Cap MRK
- 0.00%
Rendement DIV
Viemed Healthcare, Inc. (VMD) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 12.8 | 16.9 | 28.4 | ||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -2 | 0 | ||||||||
balance-sheet.row.net-receivables | 0 | 18.4 | 15.4 | 14.7 | ||||||||
balance-sheet.row.inventory | 0 | 4.6 | 3.6 | 2.5 | ||||||||
balance-sheet.row.other-current-assets | 0 | 2.4 | 3.8 | 1.7 | ||||||||
balance-sheet.row.total-current-assets | 0 | 38.2 | 39.7 | 47.3 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 76.5 | 68.4 | 62.8 | ||||||||
balance-sheet.row.goodwill | 0 | 29.6 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0.6 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 30.3 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 0 | 3.9 | 4.2 | 2.2 | ||||||||
balance-sheet.row.tax-assets | 0 | 4.5 | 3.1 | 4.8 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.7 | 1.6 | 0.9 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 115.9 | 77.3 | 70.7 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.account-payables | 0 | 4.2 | 2.6 | 3.2 | ||||||||
balance-sheet.row.short-term-debt | 0 | 2 | 0.5 | 1.9 | ||||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 6 | 0.2 | 4.6 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 19.6 | 11.1 | 8.9 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8.8 | 1.1 | 5.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.3 | 0.7 | 0.7 | ||||||||
balance-sheet.row.total-liab | 0 | 40.8 | 19.9 | 23.1 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.3 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 18.6 | 15.1 | 14 | ||||||||
balance-sheet.row.retained-earnings | 0 | 79.1 | 69.8 | 73.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.3 | -0.3 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 15.6 | 12.1 | 7.7 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 0 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 3.9 | 2.2 | 2.2 | ||||||||
balance-sheet.row.total-debt | 0 | 10.3 | 0.7 | 6.5 | ||||||||
balance-sheet.row.net-debt | 0 | -2.5 | -16.2 | -21.9 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 10.4 | 6.2 | 9.1 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 22.3 | 15.6 | 11.3 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -1.5 | 1.7 | 3.9 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 5.8 | 5.2 | 5.2 | ||||||||
cash-flows.row.change-in-working-capital | 0 | 7.9 | -10.1 | -13.6 | ||||||||
cash-flows.row.account-receivables | 0 | -1.1 | -12.6 | -7.3 | ||||||||
cash-flows.row.inventory | 0 | -0.5 | 0.3 | -0.2 | ||||||||
cash-flows.row.account-payables | 0 | -0.9 | -0.3 | 0.1 | ||||||||
cash-flows.row.other-working-capital | 0 | 10.4 | 2.4 | -6.1 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 1 | 9.1 | 6.6 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.acquisitions-net | 0 | -26.5 | -0.1 | -0.6 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -0.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -2.6 | 0 | 0.6 | ||||||||
cash-flows.row.other-investing-activites | 0 | 2.6 | 1.1 | 0.6 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -53.1 | -24 | -19.7 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.3 | -5.8 | -4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 1.3 | 0.3 | 0.1 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.6 | -9.7 | -1.4 | ||||||||
cash-flows.row.dividends-paid | 0 | -0.4 | -0.3 | -0.1 | ||||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.3 | 0.1 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2.9 | -15.3 | -5.3 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.1 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 0 | 6.9 | -11.5 | -2.6 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 12.8 | 16.9 | 28.4 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 5.9 | 28.4 | 31 | ||||||||
cash-flows.row.operating-cash-flow | 0 | 46 | 27.7 | 22.5 | ||||||||
cash-flows.row.capital-expenditure | 0 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.free-cash-flow | 0 | 19.5 | 4.8 | 2.8 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 186.4 | 138.8 | 117.1 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 72.9 | 54.2 | 43.7 | ||||||||
income-statement-row.row.gross-profit | 0 | 113.4 | 84.7 | 73.4 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.operating-expenses | 0 | 97.6 | 76.1 | 61.4 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 170.6 | 130.2 | 105 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 0.3 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 22.3 | 16.3 | 12.2 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | 15.8 | 8.3 | 11.6 | ||||||||
income-statement-row.row.income-before-tax | 0 | 14.7 | 9 | 12.5 | ||||||||
income-statement-row.row.income-tax-expense | 0 | 4.2 | 2.8 | 3.4 | ||||||||
income-statement-row.row.net-income | 0 | 10.2 | 6.2 | 9.1 |
Questions fréquemment posées
Quel est le total de Viemed Healthcare, Inc. (VMD) de l'actif total?
Viemed Healthcare, Inc. (VMD) Le total des actifs est 154102510.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.609.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.228.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.053.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.077.
Qu'est-ce que Viemed Healthcare, Inc. (VMD) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 10243000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 10271179.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 97637306.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.